About
About us
Business Model
Team
Scientific Advisors
Sevuparin
About Sevuparin
Actions of sevuparin
Further reading
Research & Development
Pipeline
About Sepsis
About anemia and CKD
About severe malaria
Sevuparin and sepsis
Sevuparin and hepcidin
Sevuparin and malaria
Investors
IPO 2021/ TO1 2022
Issues 2023
Share
News
Financial Reports
Presentations
Calendar
Corporate Governance
Analyst Coverage
News
Contact
EN
SV
Investors
Press release
BACK TO NEWS LISTING
